RE:Flyng under the radarAs those who follow my comments know, I've been a bladder cancer survivor for 5 years now and a long holder of TLTFF. I've been through 20 rounds of BCG and numerous TURBTs and cystos. Keytruda was not a consideration in my treatment plan due to extreme adverse impacts and the fact it is not a targeted immunotherapy. So any more effective and much less harmful treatments such as Theralase has can be advanced, the better for cancer patients and shareholders. Once we get notice by the FDA, off we go.